Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 103Leukemia, Myeloid, Acute 93Myelodysplastic Syndromes 84Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Non-Hodgkin 58Multiple Myeloma 57Hodgkin Disease 52Leukemia, Lymphocytic, Chronic, B-Cell 49Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 42Lymphoma, Large B-Cell, Diffuse 40Neoplasms, Plasma Cell 39Lymphoma, Follicular 39Myeloproliferative Disorders 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Myeloid, Accelerated Phase 37Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 33Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 33Blast Crisis 32Anemia, Refractory, with Excess of Blasts 31Primary Myelofibrosis 28Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Dendritic Cell Sarcoma, Interdigitating 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 20

Interventions

Epoetin Alfa 43Darbepoetin alfa 33epoetin beta 10ferric carboxymaltose 6Cyclosporine 4Cisplatin 4ferrous sulfate 3Radiotherapy 3Lenalidomide 3peginesatide 2luspatercept 2hematide 2fludarabine 2ferric gluconate 2continuous erythropoietin receptor activator 2Therapeutics 2Filgrastim 2Erythropoietin 2Dexamethasone 2Cyclophosphamide 2Brachytherapy 2Antilymphocyte Serum 2ACE-011 2thymoglobulin 1ruxolitinib 1roxadustat 1reolysin 1pegfilgrastim 1obinutuzumab 1leridistim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia × Busulfan × Clear all
NCT00987480 2018-07-10

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
45 enrolled 12 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡